Hepatitis B ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Hepatitis B Vaccine Recommendations
- MMWR, April 1, 2022, Vol 71,(13);477–83
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 - MMWR, April 20, 2018, Vol 67,(15);455-8
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant - MMWR, January 12, 2018, Vol 67,(1);1-31
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
- ACIP-VFC Resolution
ARCHIVED Hepatitis B Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, December 23, 2011, Vol 60, #50
Policy Note: Use of Hepatitis B Vaccine for Adults with Diabetes Mellitus - MMWR, October 12, 2007, Vol 56, #40
Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix®)
Print Version [28 pages] - MMWR, December 8, 2006, Vol 55, #RR16
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 2: Immunization of Adults- Appendix A | Appendix B | Appendix C
- Print version [1 MB, 40 pages] (includes appendices)
- MMWR, December 23, 2005, Vol 54, #RR16
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 1: Immunization of Infants, Children, and Adolescents- Appendix A | Appendix B | Appendix C
- Print version [1 MB, 39 pages] (includes appendices)
NOTE: If you are using the HTML versions of either of the last two recommendations, be sure to access all four links to get the complete content of the document, which includes 3 important appendices.
- MMWR, Mar 14, 2003, Vol 52, #10
Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
Print Version [24 pages] - MMWR, Sep 21, 2001, Vol 50, #37
Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
Print Version [24 pages] - MMWR, Mar 31, 2000, Vol 49, #12
Notice to Readers: Alternate Two-Dose Hepatitis B Vaccination Schedule for Adolescents Aged 11-15 Years
Print Version [28 pages] - See also:
- MMWR, December 20, 2013, Vol 62, RR10
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management
- MMWR, December 20, 2013, Vol 62, RR10